Semaglutide Treatment for Hyperglycaemia After Renal Transplantation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation — Stella

Home/Hyperglycemia/

View on ClinicalTrials.gov

Recruiting

Back to Hyperglycemia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Denmark

Department og Nephrology and Endocrinology, Rigshospitalet, Copenhagen

Key details

Phase

Post-approval study

Sponsor

Rigshospitalet, Denmark

Collaborators

Aarhus University Hospital, Odense University Hospital

Enrollment target

~104 participants

Started

September 2024

Primary completion

December 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 80 Years

Last updated December 2025